Related references
Note: Only part of the references are listed.The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses
J-X Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation
J-X Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo
Jun-Xia Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Synthesis and immunosuppressive activity of new artemisinin derivatives.: Part 2:: 2-[12(β or α)-dihydroartemisinoxymethyl-(or 1′-ethyl)]phenoxyl propionic acids and esters
Zhong-Shun Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation
Wei-Dong Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Targeting signal transduction as a strategy to treat inflammatory diseases
Luke A. J. O'Neill
NATURE REVIEWS DRUG DISCOVERY (2006)
Design of a new line in treatment of experimental rheumatoid arthritis by artesunate
A. Mirshafiey et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2006)
Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages
R Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A novel artemisinin derivative, 3-(12-β-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo
WL Zhou et al.
ACTA PHARMACOLOGICA SINICA (2005)
Synthesis and immunosuppressive activity of new artemisinin derivatives.: 1.: [12(β or α)-dihydroartemisininoxylphen(ox)yl aliphatic acids and esters
ZS Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Adaptor usage and Toll-like receptor signaling specificity
A Dunne et al.
FEBS LETTERS (2005)
Artemether: A new therapeutic strategy in experimental rheumatoid arthritis
S Cuzzocrea et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2005)
The induction of macrophage gene expression by LPS predominantly utilizes Myd88-dindependent signaling cascades
H Björkbacka et al.
PHYSIOLOGICAL GENOMICS (2004)
Immunosuppressive activity of a molecule isolated from Artemisia annua on DTH responses compared with cyclosporin A
S Noori et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation
E Aldieri et al.
FEBS LETTERS (2003)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Transcriptional and post-transcriptional control of gene expression in inflammation
M Kracht et al.
CYTOKINE (2002)
TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages
V Toshchakov et al.
NATURE IMMUNOLOGY (2002)
Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes
T Kawai et al.
JOURNAL OF IMMUNOLOGY (2001)
LPS induction of gene expression in human monocytes
M Guha et al.
CELLULAR SIGNALLING (2001)
NF-kappa B: a key role in inflammatory diseases
PP Tak et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Macrophage biology and pathobiology in the evolution of immune responses: A functional analysis
N Stoy
PATHOBIOLOGY (2001)
Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression
AE Medvedev et al.
JOURNAL OF IMMUNOLOGY (2000)
Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages
S Akashi et al.
JOURNAL OF IMMUNOLOGY (2000)